N-Cyclopentyl-6-methylpyridin-3-amine

Catalog No.: 
ACNGMO972
CAS No.: 
1521960-84-8
Molecular Formula: 
C11H16N2
Molecular Weight: 
176.26
N-Cyclopentyl-6-methylpyridin-3-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$166.00InquiryInquiry
1g95%$528.00InquiryInquiry
5g95%$2587.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Cyclopentyl-6-methylpyridin-3-amine
IUPAC NameN-cyclopentyl-6-methylpyridin-3-amine
MDL No.MFCD24119373
Molecular FormulaC11H16N2
Molecular Weight176.26
SMILESCC1=CC=C(NC2CCCC2)C=N1
InChI KeyHMVHNZSKRPDWIE-UHFFFAOYSA-N
Synonym3-Pyridinamine, N-cyclopentyl-6-methyl-
CAS No.1521960-84-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACNGMO972 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVBS901 route compound structure diagram
    ACQVBS9013430-14-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNGMO972 route product structure diagram
    ACNGMO9721521960-84-8
Inquiry

2. ACNGMO972 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBPHX970 route compound structure diagram
    ACBPHX9703430-13-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNGMO972 route product structure diagram
    ACNGMO9721521960-84-8
Inquiry

3. ACNGMO972 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQVBS901 route compound structure diagram
    ACQVBS9013430-14-6In Stock
  4. Then
  5. ACNGMO972 route product structure diagram
    ACNGMO9721521960-84-8
Inquiry

Comments (0)